文献速递外周动脉疾病

CTA钙化评分对慢性肢体威胁性缺血膝下腔内干预的预测价值

The Predictive Value of the Peripheral Arterial Calcium Scoring System on Computed Tomography Angiography in Patients With Chronic Limb-Threatening Ischemia Undergoing Below-the-Knee Endovascular Interventions.
PubMed 文献 · J Endovasc Ther · 2025-08-25

本研究基于前瞻性THRILLER注册研究,纳入419例患者473条肢体,评估基于CTA的原始与改良外周动脉钙化评分系统(PACSS/mPACSS)对膝下腔内干预后3个月结局的预测价值。多变量分析显示,PACSS 4与mPACSS ≥5均与更低的保肢率和无截肢生存率显著相关,而技术成功、一期通畅率和总生存率无显著差异。

要点

  • 基于CTA的PACSS 4是膝下腔内干预后3个月保肢和AFS的独立预测因子。
  • mPACSS ≥5同样与3个月保肢和AFS显著相关。
  • 两种评分均未显著影响技术成功、一期通畅率和总生存率。

核心结论

  • 基于CTA的PACSS和mPACSS均与膝下腔内干预后3个月保肢率和无截肢生存率显著相关。

研究设计与样本

  • 前瞻性荷兰慢性肢体威胁性缺血注册研究(THRILLER)队列分析,纳入2021年2月至2023年7月间行膝下腔内干预且术前6个月内接受CTA检查的连续患者。
  • 共纳入419例患者473条肢体,平均年龄74.1±10.2岁,男性占71.1%。

主要发现

  • 39.7%的肢体存在PACSS 4,与较高年龄及高血压、糖尿病、心血管疾病、伤口、缺血、足部感染分期、全球肢体解剖分期系统分期和支架使用率较高相关。
  • 多变量分析中,PACSS 4与较低保肢率(HR 2.75,95%CI 1.49-5.08,P=.001)和AFS(HR 1.64,95%CI 1.07-2.53,P=.025)显著相关。
  • mPACSS ≥5同样与较低保肢率(HR 2.22,95%CI 1.88-5.46,P=.015)和AFS(HR 1.68,95%CI 1.06-2.65,P=.026)显著相关。
  • 技术成功、一期通畅率和总生存率在PACSS 4与mPACSS ≥5分组间均无显著差异。

关键数值与推荐

  • PACSS 4定义及mPACSS ≥5阈值依据原文方法学,mPACSS额外考虑整个目标血管的钙化。
  • 主要结局为3个月保肢率和无截肢生存率(AFS),次要结局为技术成功、一期通畅率和总生存率。

临床怎么用

  • 对于拟行膝下腔内干预的CLTI患者,术前CTA评估PACSS或mPACSS有助于识别3个月保肢和AFS风险较高的患者。
  • CTA-based钙化评分较血管造影评分更可靠且快速,可整合入术前评估流程。
  • PACSS 4或mPACSS ≥5提示需加强围术期管理和随访,但两种评分对技术成功和一期通畅率的预测价值有限。

局限性

  • 随访时间仅3个月,无法评估长期结局。
  • 研究为观察性注册分析,存在未测量混杂可能。
  • 未直接比较PACSS与mPACSS的预测优越性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Endovascular below-the-knee (BTK) revascularization is safe and effective in patients with chronic limb-threatening ischemia (CLTI), but outcomes depend on the severity of limb ischemia, anatomical pattern, comorbidity, and degree of vessel calcification. The most commonly used peripheral calcification score, the peripheral arterial calcium scoring system (PACSS), is angiography based and is therefore limited by low sensitivity and interobserver agreement. This study aimed to determine the prognostic value of the original and a modified PACSS (mPACSS) based on computed tomography angiography (CTA) imaging on short-term outcomes after BTK endovascular interventions. MATERIALS AND METHODS: All consecutive patients included in the prospective Dutch Chronic Lower Limb-Threatening Ischemia Registry (THRILLER) between February 2021 and July 2023 who underwent CTA imaging within 6 months before the procedure were included. The mPACSS also takes calcification of the entire target vessel into account. Primary outcomes were limb salvage and amputation-free survival (AFS) at 3 months. Secondary outcomes were technical success, primary patency, and overall survival. RESULTS: In total, 419 patients with 473 limbs were included (mean age 74.1 ± 10.2 years; 71.1% male). PACSS 4 was present in 39.7% of the limbs and associated with higher age and higher rates of hypertension, diabetes mellitus, cardiovascular morbidity, wound, ischemia, foot infection stage, global limb anatomic staging system stage and use of stents. In multivariable analysis, PACSS 4 was significantly associated with lower limb salvage (hazard ratio [HR] 2.75, 95% confidence intervals [CI] 1.49-5.08, P = .001) and AFS (HR 1.64, 95% CI 1.07-2.53, P = .025), as was mPACSS ≥5 (limb salvage: HR 2.22, 95% CI 1.88-5.46, P = .015; AFS: HR 1.68, 95% CI 1.06-2.65, P = .026). No significant differences were found in terms of technical success, primary patency, and overall survival. CONCLUSION: Both PACSS and mPACSS scored on CTA imaging are significantly associated with 3-month limb salvage and AFS after BTK endovascular interventions.Clinical ImpactCurrent peripheral calcification scores are based on angiography and limited by a low sensitivity and minimal interobserver agreement. Scoring the original and modified peripheral arterial calcium scoring system (mPACSS) on computed tomography angiography (CTA) has proven to be more reliable and fast. Accordingly, this study shows that both PACSS and mPACSS scored on CTA are independent predictors of 3-month outcomes after below-the-knee interventions. This reinforces the importance of using a reliable peripheral calcification score in the preoperative assessment of CLTI patients eligible for revascularization. Future evaluations in larger cohorts with longer follow-up should investigate the PACSS and mPACSS in different clinical contexts and whether either score is superior.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Nugteren MJ, Ünlü Ç, Bakker OJ, et al. The Predictive Value of the Peripheral Arterial Calcium Scoring System on Computed Tomography Angiography in Patients With Chronic Limb-Threatening Ischemia Undergoing Below-the-Knee Endovascular Interventions. J Endovasc Ther. 2025. PMID: 40855739. doi:10.1177/15266028251363475

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。